Sort
39,280 grants matching “leukemia”
Hematalogical Malignancies
$695,190Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2018 · CA
Hematalogical Malignancies
$695,188Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2017 · CA
Animal Models of Polycythemia Vera
$695,044Jerry L Spivak · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · CA
Regulation and Manipulation of Innate Immunity During HIV Infection
$694,996Jarrod Sean Johnson · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Regulation and Manipulation of Innate Immunity During HIV Infection
$694,996Jarrod Sean Johnson · University Of Utah · R01 · FY2024 · AI
Integrated Multi-Scale Analysis of Tumor and Host Response to Therapy
$694,900Shan X. Wang · University Of Southern California · U54 · FY2013 · CA
Dissecting the canonical and non-canonical functions of Tet2 in hematopoietic stem cells and hematologic disorders
$694,860Keisuke Ito · Albert Einstein College Of Medicine · R01 · FY2019 · HL
Dissecting the canonical and non-canonical functions of Tet2 in hematopoietic stem cells and hematologic disorders
$694,860Keisuke Ito · Albert Einstein College Of Medicine · R01 · FY2022 · HL
Dissecting the canonical and non-canonical functions of Tet2 in hematopoietic stem cells and hematologic disorders
$694,860Keisuke Ito · Albert Einstein College Of Medicine · R01 · FY2021 · HL
Dissecting the canonical and non-canonical functions of Tet2 in hematopoietic stem cells and hematologic disorders
$694,860Keisuke Ito · Albert Einstein College Of Medicine · R01 · FY2020 · HL
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
$694,643Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
iPSC-based blood regenerative therapies for AIDS
$694,457Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2016 · HL
iPSC-based blood regenerative therapies for AIDS
$694,457Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2017 · HL
Investigating hematopoietic stem cell dysfunction during sickle cell disease
$694,406Shannon L McKinney-Freeman · St. Jude Children'S Research Hospital · R01 · FY2024 · HL
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$694,020Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Physical Activity to Modify Sequelae and QOL in Childhood ALL: A Nursing Trial
$693,956Cheryl Lorane Cox · St. Jude Children'S Research Hospital · R01 · FY2013 · CA
Integrated Systems Biology of Pediatric AML
$693,955Jatinder K. Lamba · University Of Florida · R01 · FY2023 · CA
Adoptive T-cell Therapies Targeting Mutations in Hematologic Malignancies
$693,831James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
$693,720Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
$693,537Christoph Rader · Basic Sciences · Z01 · FY2007 · CA
Hematalogical Malignancies
$693,252Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2016 · CA
Signal Transduction Events and the Regulation of Cell Growth
$693,164Jane B Trepel · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$693,152Irving Lerner Weissman · Stanford University · R35 · FY2017 · CA
Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins
$692,928Stephanie L. Schmit · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Gene Therapy for Hemoglobin Disorders
$692,681David M. Bodine · Human Genome Research · Z01 · FY2007 · HG